Sort   by:  
 Page size 
UnknownIntegrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
Not available
S-EPMC9988896 | biostudies-literature
UnknownLenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.
Not available
S-EPMC3418771 | biostudies-literature
UnknownLenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.
Not available
S-EPMC3901994 | biostudies-literature
UnknownPomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma.
Not available
S-EPMC5606008 | biostudies-literature
UnknownOlder patients with myeloma derive similar benefit from autologous transplantation.
Not available
S-EPMC4194262 | biostudies-literature
UnknownMaternal and Newborn Hospital Outcomes of Perinatal SARS-CoV-2 Infection: A National Registry.
Not available
S-EPMC11292484 | biostudies-literature
UnknownSARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Not available
S-EPMC7995808 | biostudies-literature
UnknownSARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Not available
S-EPMC8652887 | biostudies-literature
UnknownTiming of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Not available
S-EPMC8206995 | biostudies-literature
UnknownExtended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929 | biostudies-literature
Sort   by:  
 Page size